The bone marker plot: An innovative method to assess bone turnover in women

European Journal of Clinical Investigation

Volumn 39, Issue 3, 2009, Pages 230-238

  Bieglmayer, C ^a,b   Kudlacek, S ^c,d  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

^d Krankenhaus der Barmherzigen Brder   (Austria)

Author keywords

Bone turnover; Graphic report; Marker

Indexed keywords

COLLAGEN; OSTEOCALCIN; PARATHYROID HORMONE[1-34]; PROCOLLAGEN TYPE 1 AMINOPROPEPTIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE TURNOVER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MATHEMATICAL ANALYSIS; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; POSTMENOPAUSE; PRIORITY JOURNAL;

ADULT; AGED; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; BONE RESORPTION; FEMALE; HUMANS; MIDDLE AGED; MODELS, THEORETICAL; PERIMENOPAUSE; POSTMENOPAUSE; PREMENOPAUSE; REFERENCE VALUES; TIME FACTORS;

EID: 61349187695     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2009.02087.x     Document Type: Article

References (38)

1. Christenson RH. Biochemical markers of bone metabolism: an overview. Clin Biochem 1997 30 : 573 93.
2. Ganero P, Delmas PD. Biochemical markers of bone turnover: applications for osteoporosis. Endocrinol Metab Clin North Am 1998 27 : 303 23.
3. Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J. The use of biochemical markers of bone turnover in osteoporosis. Osteoporos Int 2000 11 (Suppl. 6 S2 17.
4. Seibel MJ. Biochemical markers of bone remodeling. Endocrinol Metab Clin North Am 2003 32 : 83 113.
5. Seibel MJ. Biochemical markers of bone metabolism in the assessment of osteoporosis: useful or not? J Endocrinol Invest 2003 26 : 464 71.
6. Szulc P, Delmas PD. Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis. Osteoporos Int 2008 19 : 1683 704.
7. Ivaska KK, Lenora J, Gerdhem P, Akesson K, Väänänen HK, Obrant KJ. Serial assessment of serum bone metabolism markers identifies women with the highest rate of bone loss and osteoporosis risk. J Clin Endocrinol Metab 2008 93 : 2622 32.
8. Garnero P, Sornay-Rendu E, Duboeuf F, Delmas PD. Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study. J Bone Miner Res 1999 14 : 1614 21.
9. Srivastava AK, Vliet EL, Lewiecki EM, Maricic M, Abdelmalek A, Gluck O et al. Clinical use of serum and urine bone markers in the management of osteoporosis. Curr Med Res Opin 2005 21 : 1015 26.
10. Chesnut CH 3rd, Bell NH, Clark GS, Drinkwater BL, English SC, Johnson CC Jr. et al. Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density. Am J Med 1997 102 : 29 37.
11. Bauer DC, Skarin PM, Stone KL, Black DM, Nevitt MC, Ensrud KE et al. Biochemical markers of bone turnover and prediction of hip bone loss in older women: the study of osteoporotic fractures. J Bone Miner Res 1999 14 : 1404 10.
12. Iki M, Morita A, Ikeda Y, Sato Y, Akiba T, Matsumoto T et al. Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women - the Japanese Population-based Osteoporosis (JPOS) Cohort Study. Osteoporos Int 2006 17 : 1086 95.
13. Lenora J, Ivaska KK, Obrant KJ, Gerdhem P. Prediction of bone loss using biochemical markers of bone turnover. Osteoporos Int 2007 18 : 1297 305.
14. Iki M, Morita A, Ikeda Y, Sato Y, Akiba T, Matsumoto T et al. Biochemical markers of bone turnover may predict progression to osteoporosis in osteopenic women: the JPOS cohort study. J Bone Miner Metab 2007 25 : 122 9.
15. Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J Bone Miner Res 1996 11 : 1531 8.
16. Van Daele PL, Seibel MJ, Burger H, Hofman A. Grobbee DE, van Leeuwen JP et al. Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study. BMJ 1996 312 : 482 3.
17. Ross PD. Predicting bone loss and fracture risk with biochemical markers: a review. J Clin Densitom 1999 2 : 285 94.
18. Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res 2000 15 : 1526 36.
19. Chapurlat RD, Ganero P, Bréart G, Meunier PJ, Delmas PD. Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women: the EPIDOS study. Bone 2000 27 : 283 6.
20. Hannon RA, Eastell R. Biochemical markers of bone turnover and fraction prediction (review). J Br Menopause Soc 2003 9 : 10 5.
21. Bruyere O, Colette J, Delmas P, Rouillon A, Roux C, Seidel L et al. Interest of biochemical markers of bone turnover for long-term prediction of new vertebral fracture in postmenopausal osteoporotic women. Maturitas 2003 44 : 259 65.
22. Stepan JJ. Clinical utility of bone markers in the evaluation and follow-up of osteporotic patients: why are the markers poorly accepted by clinicians? J Endocrinol Invest 2003 26 : 458 63.
23. Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 1994 79 : 1693 700.
24. Christgau S, Bitsch-Jensen O, Bjarnson HN, Henriksen GE, Qvist P, Alexandersen P et al. Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy. Bone 2000 26 : 505 11.
25. Greenspan SL, Rosen HN, Parker RA. Early changes in serum N-telopeptide and C-telopeptide crosslinked collagen type I predict long-term response to alendronate therapy in elderly women. J Clin Endocrinol Metab 2000 85 : 3537 40.
26. Christiansen C, Tankó LB, Warming L, Moelgaard A, Christgau S, Qvist P et al. Dose dependent effects on bone resorption and formation of intermittently administered intravenous ibandronate. Osteoporos Int 2003 14 : 609 13.
27. Raisz L, Smith JA, Trahiotis M, Fall P, Shoukri K, Digennaro J et al. Short-term risedronate treatment in postmenopausal women: effects on biochemical markers of bone turnover. Osteoporos Int 2000 11 : 615 20.
28. Dobnig H, Sipos A, Jiang Y, Fahrleitner-Pammer A, Ste-Marie LG, Gallagher C et al. Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy. J Clin Endocrinol Metab 2005 90 : 3970 7.
29. Reginster JY, Collette J, Neuprez A, Zegels B, Deroisy R, Bruyere O. Role of biochemical markers of bone turnover as prognostic indicator of successful osteoporosis therapy. Bone 2008 42 : 832 6.
30. Chen P, Satterwhite JH, Licata AA, Lewiecki EM, Sipos AA, Misurski DM et al. Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis. J Bone Miner Res 2005 20 : 962 70.
31. Kudlacek S, Schneider B, Peterlik M, Leb G, Klaushofer K, Weber K et al. Normative data of bone mineral density in an unselected adult Austrian population. Eur J Clin Invest 2003 33 : 332 9.
32. Kudlacek S, Schneider B, Peterlik M, Leb G, Klaushofer K, Weber K et al. Assessment of vitamin D and calcium status in healthy adult Austrians. Eur J Clin Invest 2003 33 : 323 31.
33. Kanis JA, Melton L III, Christiansen C, Johnston C, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994 9 : 1137 41.
34. Garnero P, Vergnaud P, Hoyle N. Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosis. Clin Chem 2008 54 : 188 96.
35. Cuckle HS, Wald NJ, Thompson SG. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 1987 94 : 387 402.
36. Eastell R, Robins SP, Colwell T, Assiri AMA, Riggs BL, Russel GG. Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption. Osteoporos Int 1993 3 : 255 60.
37. Landtwing S. Airborne Laser Scanning. Diploma Thesis. Swiss Federal Institute of Technology Zurich, 2005. Available at http://www.geometh-data.ethz. ch/publicat/diploma/landtwing2005/Bilder/Da-Landtwing.pdf (accessed January 30, 2009).
38. Schwarze B, Schönfelder S. ArcView-extension VISAR-Visualisierung von Aktionsräumen. Progress Report Traffic and Spatial Planning 95, Institute for Traffic Planning and Transportation Research, Swiss Federal Institute of Technology Zurich, 2001. Available at http://e-collection.ethbib. ethz.ch/ecol-pool/incoll/incoll-488.pdf (accessed January 30, 2009).